This inventor holds 8 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Eurofins Lifecodexx Gmbh, Lifecodexx Ag, Lifecodexx. Active years: 2017-2024.
Company Filing History:
Years Active: 2017-2024
Title: Wera Hofmann: Innovator in DNA Detection Technologies
Introduction
Wera Hofmann is a prominent inventor based in Constance, Germany. She has made significant contributions to the field of DNA detection, holding a total of 8 patents. Her work focuses on innovative methods that enhance the detection of specific cell-type DNA, which has important applications in medical diagnostics.
Latest Patents
Hofmann's latest patents include groundbreaking methods for detecting DNA that originates from specific cell types. One of her notable inventions involves the detection of cell-free DNA from biological fluids, particularly in pregnant females. This method utilizes differential methylation to distinguish between DNA from the target cells and other DNA present in the sample. The implications of her work are profound, as it aids in diagnosing conditions such as preeclampsia and cancer, and assists in detecting chromosomal trisomy in fetuses, including in twin pregnancies. Additionally, her patents encompass compositions, kits, and computer program products that facilitate the application of these methods.
Career Highlights
Throughout her career, Wera Hofmann has worked with notable companies, including Eurofins Lifecodexx GmbH and Lifecodexx AG. Her experience in these organizations has allowed her to refine her expertise in DNA detection technologies and contribute to advancements in the field.
Collaborations
Hofmann has collaborated with several professionals in her field, including Hamed Said and Sebastian Gromminger. These partnerships have further enriched her research and development efforts.
Conclusion
Wera Hofmann's innovative work in DNA detection technologies has positioned her as a leading inventor in the medical diagnostics field. Her contributions continue to have a significant impact on healthcare and patient outcomes.